Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback